Journal Information

Statistics

Follow this link to access the full text of the article

Original article
A Phase Ib open label, randomized, safety study of SANGUINATE™ in patients with sickle cell anemia
Hemant Misraa,
Corresponding author
hmisra@prolongpharma.com

Corresponding author at: Clinical Development, 300B Corporate Court, South Plainfield, NJ 07080, United States.
, James Bainbridgea, John Berrymana, Abraham Abuchowskia, Kenneth Mauricio Galvezb, Luis Fernando Uribec, Angel Luis Hernandezd, Nestor Rodolfo Sosae
a Prolong Pharmaceuticals, South Plainfield, United States
b Hospital Pablo Tobon Uribe, Medellin, Colombia
c Fundación Reina Isabel, Cali, Colombia
d Fundación BIOS, Barranquilla, Colombia
e Pan American Medical Research Institute, Pamri, Panama
Read
2187
Times
was read the article
611
Total PDF
1576
Total HTML
Share statistics
Article information
ISSN: 15168484
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 6 8 5 13
2025 5 62 12 74
2025 4 38 17 55
2025 3 62 14 76
2025 2 57 29 86
2025 1 44 21 65
2024 12 33 18 51
2024 11 57 24 81
2024 10 227 22 249
2024 9 71 23 94
2024 8 50 23 73
2024 7 69 25 94
2024 6 44 30 74
2024 5 213 20 233
2024 4 46 23 69
2024 3 41 20 61
2024 2 47 29 76
2024 1 73 28 101
2023 12 59 31 90
2023 11 76 54 130
2023 10 45 38 83
2023 9 44 39 83
2023 8 19 15 34
2023 7 22 15 37
2023 6 28 14 42
2023 5 28 14 42
2023 4 13 8 21
Show all

Follow this link to access the full text of the article

Idiomas
Hematology, Transfusion and Cell Therapy